ANDE three-lens brief
Evidence-based stock research on ANDE. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · Negative free cash flow last quarterly (-$109.11M).
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Analyst mean target $88.33 — 23% above current (3 analysts).
- Negative free cash flow last quarterly (-$109.11M).
ANDE closed at $71.88 (+0.79%) as of 2026-09-11. Market cap: $2.45B. P/E (trailing) 13.8. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; analyst mean target $88.33 — 23% above current (3 analysts).. Concerns: negative free cash flow last quarterly (-$109.11M).. Last quarter: Revenue $3.10B, net income $56.56M, free cash flow -$109.11M.
Why three lenses on ANDE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ANDEacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ANDE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ANDE brief"></iframe>